Literature DB >> 10528183

Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.

P Shier1, K Ngo, W P Fung-Leung.   

Abstract

Signaling through the TCR as well as engagement of costimulatory molecules are required for efficient T cell activation and progression into differentiated effector cells. The beta2 integrin LFA-1 (CD11a/CD18) has been implicated in TCR costimulation as well as in cell-cell adhesion function, but its exact role is still ambiguous. The present study focuses on the requirement for LFA-1 in CD8+ T cell activation and effector function using LFA-1-deficient cells expressing the 2C transgenic TCR as a model system. The lack of LFA-1 expression in 2C T cells resulted in severely diminished proliferative response toward allogeneic BALB/c splenocytes. Increase in TCR signaling alone by pulsing stimulators with high affinity peptides, p2Ca or QL9, had minimal effects in restoring proliferation. Addition of exogenous IL-2, however, enhanced the effect of peptide pulsing on proliferation of LFA-1-deficient 2C T cells. LFA-1-deficient 2C CTLs generated from alloantigen stimulation exhibited a defective cytotoxic activity when tested on a variety of target cells. Cytolysis could be improved, but not fully rectified by peptide pulsing of target cells. Thus, in the 2C TCR model, LFA-1 has a requisite role for optimal CD8+ T cell activation and effector function, which cannot be overcome by increasing peptide/MHC density on either the APCs or target cells, respectively.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10528183

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  LFA-1-mediated T cell costimulation through increased localization of TCR/class II complexes to the central supramolecular activation cluster and exclusion of CD45 from the immunological synapse.

Authors:  Beth Graf; Timothy Bushnell; Jim Miller
Journal:  J Immunol       Date:  2007-08-01       Impact factor: 5.422

Review 2.  Review article: molecular signals and genetic reprogramming in peripheral T-cell differentiation.

Authors:  A Noble
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

3.  Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.

Authors:  David L Tamang; Doug Redelman; Bryce N Alves; Leanne Vollger; Christy Bethley; Dorothy Hudig
Journal:  Cytokine       Date:  2006-12-22       Impact factor: 3.861

4.  Differential Interleukin-2 Transcription Kinetics Render Mouse but Not Human T Cells Vulnerable to Splicing Inhibition Early after Activation.

Authors:  Debojit Bose; Alexander Neumann; Bernd Timmermann; Stefan Meinke; Florian Heyd
Journal:  Mol Cell Biol       Date:  2019-07-29       Impact factor: 4.272

5.  Proline-rich tyrosine kinase-2 is critical for CD8 T-cell short-lived effector fate.

Authors:  Sören Beinke; Hyewon Phee; Jonathan M Clingan; Joseph Schlessinger; Mehrdad Matloubian; Arthur Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

6.  Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-alpha on cytokine-activated T cells.

Authors:  Chinh N Tran; Steven K Lundy; Peter T White; Judith L Endres; Christopher D Motyl; Raj Gupta; Cailin M Wilke; Eric A Shelden; Kevin C Chung; Andrew G Urquhart; David A Fox
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

7.  Transient Surface CCR5 Expression by Naive CD8+ T Cells within Inflamed Lymph Nodes Is Dependent on High Endothelial Venule Interaction and Augments Th Cell-Dependent Memory Response.

Authors:  David Askew; Charles A Su; Deborah S Barkauskas; R Dixon Dorand; Jay Myers; Rachel Liou; Joseph Nthale; Alex Y Huang
Journal:  J Immunol       Date:  2016-03-18       Impact factor: 5.422

8.  Alloreactive (CD4-Independent) CD8+ T cells jeopardize long-term survival of intrahepatic islet allografts.

Authors:  K E Lunsford; K Jayanshankar; A M Eiring; P H Horne; M A Koester; D Gao; G L Bumgardner
Journal:  Am J Transplant       Date:  2008-06       Impact factor: 8.086

9.  Structural modifications of ICAM-1 cyclic peptides to improve the activity to inhibit heterotypic adhesion of T cells.

Authors:  Bimo A Tejo; Usman S F Tambunan; Gennady Verkhivker; Teruna J Siahaan
Journal:  Chem Biol Drug Des       Date:  2008-06-11       Impact factor: 2.817

Review 10.  Alpha E: no more rejection?

Authors:  Peter J Kilshaw; Jonathan M G Higgins
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.